Proactive Therapeutic Drug Monitoring of Adalimumab in Patients With Crohn's Disease

被引：4
|
作者：
Papamichael, Konstantinos [1 ]
Dubinsky, Marla C. [2 ]
Cheifetz, Adam S. [1 ]
机构：
[1] Harvard Med Sch, Ctr Inflammatory Bowel Dis, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02115 USA
[2] Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY USA
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 01期
关键词：
BIOLOGICS;
D O I：
10.1053/j.gastro.2022.04.014
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：164 / 165
页数：2
相关论文
共 50 条
  • [21] LOW RATES OF SUBTHERAPEUTIC DRUG LEVELS ARE OBSERVED WITH PROACTIVE THERAPEUTIC DRUG MONITORING OF ADALIMUMAB
    Shields, Stephanie
    Seenan, John Paul
    Dunlop, Allan
    Galloway, Peter
    Macdonald, Jonathan
    GUT, 2021, 70 : A121 - A122
  • [22] Therapeutic Drug Monitoring in Perianal Fistulizing Crohn's Disease
    Zulqarnain, Mir
    Deepak, Parakkal
    Yarur, Andres J.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [23] Comparison of adalimumab drug levels and drug survival in proactive vs reactive therapeutic drug monitoring
    Shields, S.
    Dunlop, A.
    Barry, S.
    Galloway, P.
    Seenan, J. P.
    Macdonald, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I347 - I348
  • [24] Comparison of adalimumab drug levels and drug survival in proactive vs reactive therapeutic drug monitoring
    Shields, S.
    Dunlop, A.
    Barry, S.
    Galloway, P.
    Seenan, J. P.
    Macdonald, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I347 - I348
  • [25] The impact of proactive versus reactive drug monitoring of infliximab on treatment outcomes in patients with crohn's disease
    Zhang, Yue
    Jiang, Wenyu
    Xu, Chenjing
    Tian, Jiahui
    Chen, Jie
    Zhang, Hongjie
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2024, 59 (03) : 269 - 279
  • [26] Therapeutic Drug Monitoring of Adalimumab During Long-term Follow-up in Paediatric Patients With Crohn Disease
    Kim, Mi Jin
    Kim, Eunsil
    Kang, Ben
    Choe, Yon Ho
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2021, 72 (06): : 870 - 876
  • [27] A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn's disease
    Willeman, Theo
    Jourdil, Jean-Francois
    Gautier-Veyret, Elodie
    Bonaz, Bruno
    Stanke-Labesque, Francoise
    ANALYTICA CHIMICA ACTA, 2019, 1067 : 63 - 70
  • [28] Achieving biochemical remission with adalimumab therapy using therapeutic drug monitoring: Results of a large prospective Crohn's disease cohort
    Plevris, N.
    Jenkinson, P.
    Chuah, C. S.
    Lyons, M.
    Hall, R.
    Jones, G.
    Watson, E.
    Arnott, I.
    Lees, C.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S79 - S80
  • [29] Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring
    Assa, Amit
    Matar, Manar
    Turner, Dan
    Broide, Efrat
    Weiss, Batia
    Ledder, Oren
    Guz-Mark, Anat
    Rinawi, Firas
    Cohen, Shlomi
    Topf-Olivestone, Chani
    Shaoul, Ron
    Yerushalmi, Baruch
    Shamir, Raanan
    GASTROENTEROLOGY, 2019, 157 (04) : 985 - +
  • [30] Safety of adalimumab in patients with Crohn's disease
    Reactions Weekly, 2018, 1708 (1) : 13 - 13
12345